Abstract
Sporadic prion disease is an unusual condition in Latin American populations. The etiology is genetic alteration that causes an aberrant misfolded protein that accumulates in various encephalic structures, generating rapid dementia and subsequently variables neurological deficits. The aim is to present a particular multisystem impairment related to the sporadic variant of Creutzfeldt-Jakob disease that this fact makes it a diagnostic challenge
References
POLO JM. The history and classification of human prion diseases, Rev Neurol 2000; 31 (2):137-4.
GAJDUSEK DC, GIBBS CJ JR, ALPERS M. Experimental transmission of a Kurulike syndrome to chimpanzees. Nature 1966; 209:7946.
GIBBS CJ JR, GAJDUSEK DC, ASHER DM, ALPERS MP, BECK E, DANIEL PM, ET AL. Creutzfeldt Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968;161:3889.
PRUSINER SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-144
CLARKE A., JACKSON GS., COLLINGE J. The molecular biology of prion propagation Philos Trans R Soc Lond B Biol Sci 2001;356:185-95.
ANDINO A., ARÍZAGA E. Enfermedades neurodegenerativas en el Hospital de Especialidades Eugenio Espejo, período 2000-2012. (Tesis de Grado). Quito: Universidad Central del Ecuador; 2013.
ALARCÓN F, SALINAS R, RÁBANO A. Enfermedad de Creutzfeldt Jakob Esporádico: Presentación del Primer Caso Clínico - Patológico en Ecuador. Rev Neuro 2009; 18(3):45-48.
SÁNCHEZ J, CENTANARO M, KUON YENG J. LUCERO S, LARA T. Enfermedad de Creutzfeldt-Jakob. Presentación de un caso clínico y revisión de la literatura. Rev Neuro 2009; 21(3):36-39.
ZERR I, KALLENBERG K, SUMMERS DM, ROMERO C, TARATUTO A, HEINEMANN U, BREITHAUPT M, ET AL. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(10):2659-68.
IRONSIDE JW. Creutzfeldt-Jakob disease. Brain Pathol 1996;6:379-88.
VAN DIJK JMC, BRUGGE KC, WILLINSKY RA, WALLACE MC. Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke 2002; 33:1233-6.
KANO S, OGAWA K. Auris Creutzfeldt-Jakob disease, hyperparathyroidism presentation Nasus laringe. 2000; 27(3):281-3.
BODEMER W, KAUP FJ. Basic research on the transmission of BSE to humans. Dtsch Tierarztl Wochenschr. 2002;109(8) 338-41.
PRIOLA SA, VORBERG I. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Methods Mol Biol. 2004;268:517-40.
FEREN?ÍK M1, NOVÁK M, MIKULA I, J. Sokol. Prions - neurodegenerative diseases caused by prions, protein molecules offectious. Bratisl Lek Listy. 1998; 99 (8-9):486-98.
HALLIDAY M, RADFORD H, MALLUCCI GR. Prions: the generation and spread against neurotoxicity. J Biol Chem. 2014; 289 (29):19862-8.
MORENO JA, HALLIDAY M, MOLLOY C, RADFORD H, VERITY N, AXTEN JM, ET AL. Oral therapy targeting the unfolded protein response prevents clinical disease and neurodegeneration in prion-infected mice. Sci Transl Med. 2013;5(206): 206-138.
MORENO JA, RADFORD H, PERETTI D, STEINERT JR, VERITY N, MARTIN MG, ET AL. Supported by translational repression eIF2?-P half prion neurodegeneration. Science. 2012; 485(7399):507-11.
ZHOU M, OTTENBERG G, SFERRAZZA GF, HUBBS C, FALLAHI M, RUMBAUGH G, ET AL. Induced by misfolded prion protein is neuronal death due to depletion of NAD + and can be relieved in vitro and in vivo replacement for NAD +. Brain. 2015; 138 (4): 992-1008.
YUAN Z, YANG L, CHEN B, ZHU T, HASSAN MF, YIN X. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein PrP oligomers cause neuronal apoptosis. J Neurochem. 2015; 133(5):722-9.
PEDERSEN NS, SMITH E. Prion diseases: epidemiology in man. APMIS. 2002;110(1):14-22.
SAMMAN I, SCHULZ-SCHAEFFER WJ, WÖHRLE JC, SOMMER A, KRETZSCHMAR HA, HENNERICI M. Clinical and magnetic resonance range in Creutzfeldt-Jakob heterozygosity at codon 129 and Type 2 prion protein. J Neurol Neurosurg Psychiatry. 1999; 67(5):678-81.
PARCHI P, GIESE A, CAPELLARI S, BROWN P, SCHULZ-SCHAEFFER W, WINDL O, ET AL. Classification of Sporadic Creutzfeldt- Jakob Disease Based on Molecular and Phenotypic Analysis of 300 Subjects. Ann Neurol. 1999; 46(falta mencionar el número): 224-233.
CASTELLANI R.J., COLUCCI M, XIE Z, ZOU W, LI C, PARCHI P, ET AL. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology. 2004; 63: 436-442.
ZERR I, SCHULZ-SCHAEFFER W, GIESE A, BODEMER M, SCHROTER A, HENKEL K, ET AL. Current Clinical Diagnosis in Creutzfeldt-Jakob Disease: Identification of Uncommon Variants. Ann Neurol 2000; 48:323-329.
KOJIMA G1, TATSUNO BK, INABA M, VELLIGAS S, MASAKI K, LIOW KK. Creutzfeldt-Jakob disease: a case report and differential diagnosis. Hawaii J Med Public health. 2013; 72(4):136-9.
GOEDERT M. Alzheimer's and Parkinson's diseases: The prion concept regarding Aß assembly, tau and ?-synuclein. Science. 2015; 349 (6248):1255-555.
SZWED A1, MI?OWSKA K. The role of proteins in neurodegenerative disease. Postepy Hig Med Dosw. 2012; 66: 187-95.
IRONSIDE JW, JEFE MW. Neuropathology and molecular biology of variant Creutzfeldt-Jakob. Curr Top Microbiol Immunol. 2004; 284:133-59.
VAN EVERBROECK B, BENDICIONES J, CRAS P. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg. 2005; 107(5):355-60.
CAMBIER DM, KANTARCI K, WORRELL GA, WESTMORELAND BF, AKSAMIT AJ. Lateralized abnormalities and focal clinical, EEG and MRI FLAIR Creutzfeldt-Jakob. Clin Neurophysiol. 2003; 114(9):1724-8.
MEISSNER B1, KALLENBERG K, SÁNCHEZ-JUAN P, COLLIE D, SUMMERS DM, ALMONTI S, ET AL. Profiles MRI lesions Creutzfeldt-Jakob sporadic. Neurol. 2009; 72(23):1994-2001.
MÉNDEZ OE, SHANG J, JUNGREIS CA. KAUFER DI. Diffusion weighted MRI in Creutzfeldt-Jakob disease: better diagnostic marker CSF 14-3-3 protein?. J Neuroimagen. 2003; 13 (2):147-51.
KANDIAH N, TAN K, PAN AB, AU WL, VENKETASUBRAMANIAN N, TCHOYOSON, ET AL. Creutzfeldt-Jakob disease: that the diffusion-weighted images anomaly is associated with complex EEG papers?. J Neurol. 2008; 255(9):1411-4.
VAN EVERBROECK B, BENDICIONES J, CRAS P. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg. 2005;107(5): 355-60.
SATOH K, SHIRABE S, TSUJINO A, EGUCHI H, M MOTOMURA, HONDA H, ET AL. Total tau protein in the cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker of Creutzfeldt-Jakob. Dement Geriatr Cogn Disord. 2007;24 (3):207-12.
SATOH K, SHIRABE S, EGUCHI H, TSUJINO A, MOTOMURA M, SATOH A, ET AL. Chronological changes on MRI and CSF biochemical markers in patients with Creutzfeldt-Jakob. Dement Geriatr Cogn Disord. 2007;23(6):372-81.
KOVANEN J. Clinical characteristics of familial and sporadic Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand. 1993; 87(6):469-74.
HOLMES BB, DIAMANTE MI. Prion protein Tau properties as: the importance of the extracellular Tau as a therapeutic target. J Biol Chem. 2014; 289(29):19855-61.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.